APYX MEDICAL CORPORATION's ticker is APYX and the CUSIP is 03837C106. A total of 69 filers reported holding APYX MEDICAL CORPORATION in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,472,669 | +45.2% | 460,209 | +128.3% | 0.00% | – |
| Q2 2023 | $1,013,907 | +338999.3% | 201,572 | +94.3% | 0.00% | – |
| Q1 2023 | $299 | -11.0% | 103,755 | -27.8% | 0.00% | – |
| Q4 2022 | $336 | -100.0% | 143,774 | -27.3% | 0.00% | -100.0% |
| Q3 2022 | $888,000 | -58.7% | 197,785 | -46.1% | 0.00% | 0.0% |
| Q2 2022 | $2,148,000 | +185.3% | 366,627 | +217.8% | 0.00% | – |
| Q1 2022 | $753,000 | +8.2% | 115,362 | +112.5% | 0.00% | – |
| Q4 2021 | $696,000 | +30.3% | 54,287 | +40.9% | 0.00% | – |
| Q3 2021 | $534,000 | -62.4% | 38,532 | -72.1% | 0.00% | -100.0% |
| Q2 2021 | $1,422,000 | +668.6% | 137,963 | +619.4% | 0.00% | – |
| Q1 2021 | $185,000 | -29.1% | 19,178 | -47.2% | 0.00% | – |
| Q4 2020 | $261,000 | +128.9% | 36,304 | +50.6% | 0.00% | – |
| Q3 2020 | $114,000 | -96.2% | 24,110 | -95.0% | 0.00% | -100.0% |
| Q1 2019 | $3,031,000 | – | 480,327 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Archon Capital Management LLC | 3,452,030 | $11,046,496 | 2.90% |
| AIGH Capital Management LLC | 1,895,231 | $6,064,739 | 2.87% |
| Taylor Frigon Capital Management LLC | 621,147 | $1,987,670 | 1.10% |
| Worth Venture Partners, LLC | 462,606 | $1,480,339 | 0.88% |
| PERKINS CAPITAL MANAGEMENT INC | 211,800 | $678 | 0.67% |
| PURA VIDA INVESTMENTS, LLC | 836,990 | $2,678,368 | 0.51% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 372,106 | $1,190,739 | 0.19% |
| GREENWOOD CAPITAL ASSOCIATES LLC | 301,809 | $965,789 | 0.14% |
| RTW INVESTMENTS, LP | 1,777,194 | $5,687,021 | 0.12% |
| Legato Capital Management LLC | 140,062 | $448,198 | 0.06% |